Postmenopausal Hormone Therapy

Postmenopausal Hormone Therapy - most related articles:

- Cancer risk found for long-term hormone therapy - 10.1
- Less hormone therapy use in women reduced breast cancer rate - 7.7
- Hormone therapy at menopause may lead to breast cancer - 6.5
- HRT-breast cancer risk stays same regardless of family history - 6.4
- Combined hormone therapy increases lobular breast cancer risk - 6.2
- Hormone therapy may increase ovarian cancer risk - 6
- Long term hormone therapy linked to higher breast cancer risk - 5.9
- Breast cancer relapse risk low after 5 years - 5.5
- Hormone therapy reduces woman's risk of colorectal cancer by 40% - 5.3
- Combined hormone therapy makes breast cancer detection difficult - 4.6

Postmenopausal Hormone Therapy articles

Cancer risk found for long-term hormone therapy
Using postmenopausal hormone therapy for more than 15 years increases a woman's risk of developing breast cancer, particularly among leaner women according to research at the Keck School of Medicine of the University of Southern California (USC).

Less hormone therapy use in women reduced breast cancer rate
The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.

Hormone therapy may increase ovarian cancer risk
Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer.

HRT-breast cancer risk stays same regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of Rochester Medical Center study concluded.

Hormone therapy reduces woman's risk of colorectal cancer by 40%
In a large study, a national team of researchers led by Mayo Clinic scientists observed that self-reported use of hormone therapy was associated with a significantly lower colorectal cancer risk. However, the mechanisms for the apparent protective association are still unclear.

Combined hormone therapy increases lobular breast cancer risk
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.

6 Postmenopausal Hormone Therapy articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
0.91